Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy

Article English OPEN
Felix Koukouikila-Koussounda; Sankarganesh Jeyaraj; Christian N. Nguetse; Charles Nchotebah Nkonganyi; Kossiwa Clarisse Kokou; Mandingha K. Etoka-Beka; Francine Ntoumi; Thirumalaisamy P. Velavan;
  • Publisher: BioMed Central
  • Journal: Malaria Journal,volume 16 (issn: 1475-2875, eissn: 1475-2875)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.1186/s12936-017-1816-x, pmc: PMC5395861
  • Subject: Anti-malarial resistance | Pfmdr1 | Pfatp6 | Malaria | Republic of Congo | Pfk13 | Research | RC955-962 | RC109-216 | ACT | Pfcrt | Plasmodium falciparum | Infectious and parasitic diseases | Arctic medicine. Tropical medicine
    mesheuropmc: parasitic diseases

Abstract Background Resistance to anti-malarial drugs hinders efforts on malaria elimination and eradication. Following the global spread of chloroquine-resistant parasites, the Republic of Congo adopted artemisinin-based combination therapy (ACT) in 2006 as a first-lin... View more
Share - Bookmark